- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was speedy delete. CSD§G5: creation by blocked user in violation of the block, see Wikipedia:Sockpuppet investigations/Sibtain 007 Callanecc (talk • contribs • logs) 04:13, 20 April 2014 (UTC)[reply]
- Ark Sciences (edit | talk | history | protect | delete | links | watch | logs | views) – (View log · Stats)
- (Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
Company only notable for the one drug it produces. Article re-created on April 6 by suspected-but-not-proven sockpuppet of a banned user (see article talk page, page history, page logs, and user page of the now-blocked editor, and archive of the SPI listed on that user page). References are wholly inadequate to demonstrate notability. Due to repeated re-creation I recommend Deletion with the creation of a protected redirect pointing to the drug the company makes, Zeuterin. davidwr/(talk)/(contribs) 19:44, 19 April 2014 (UTC)[reply]
- – NorthAmerica1000 21:17, 19 April 2014 (UTC)[reply]
- Comment The references you are citing pretty firmly establish the notability of the drug Zeuterin. Unfortunately they mention the company only in passing. -Ad Orientem (talk) 21:27, 19 April 2014 (UTC)[reply]
- Note: This debate has been included in the list of Business-related deletion discussions. ///EuroCarGT 21:30, 19 April 2014 (UTC)[reply]
- Note: This debate has been included in the list of New York-related deletion discussions. ///EuroCarGT 21:30, 19 April 2014 (UTC)[reply]
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.